Stockreport

89bio Inc (ETNB) Reports Increased R&D Spend and Strengthened Cash Position in Q4 and Full ... [Yahoo! Finance]

89bio, Inc.  (ETNB) 
Last 89bio, inc. earnings: 3/18 04:05 pm Check Earnings Report
PDF R&D Expenses : R&D expenses rose to $33.6 million for Q4 and $122.2 million for the full year, reflecting increased investment in clinical programs. G&A Expenses : G& [Read more]